부산대학교 도서관

Davids, Matthew S ; Lampson, Benjamin L ; Tyekucheva, Svitlana ; Wang, Zixu ; Lowney, Jessica C ; Pazienza, Samantha ; Montegaard, Josie ; Patterson, Victoria ; Weinstock, Matthew ; Crombie, Jennifer L ; Ng, Samuel Y ; Kim, Austin I ; Jacobson, Caron A ; LaCasce, Ann S ; Armand, Philippe ; Arnason, Jon E ; Fisher, David C ; Brown, Jennifer R

In The Lancet Oncology October 2021 22(10):1391-1402

Fiore, Danilo; Cappelli, Luca Vincenzo; Zhaoqi, Liu; Kotlov, Nikita; Sorokina, Maria; Phillip, Jude; Zumbo, Paul; Yoffe, Liron; Ghione, Paola; Wang, Anqi; Han, Xueshuai; Taylor, Abigail; Chiu, William; Fragliasso, Valentina; Tabbo, Fabrizio; Zamponi, Nahuel; Di Siervi, Nicolás; Kayembe, Clarisse; Medico, Giovanni; Patel, Ruchi P; Gaudiano, Marcello; Machiorlatti, Rodolfo; Astone, Giuseppina; Cacciapuoti, Maria Teresa; Zanetti, Giorgia; Pignataro, Claudia; Eric, Ruiz Arvin; Patel, Sanjay; Zammarchi, Francesca; Zanettini, Claudio; Queiroz, Lucio; Nikitina, Anastasia; Kudryashova, Olga; Karelin, Anton; Nikitin, Daniil; Tychinin, Dmitry; Postovalova, Ekaterina; Bagaev, Alexander; Svekolkin, Viktor; Belova, Ekaterina; Tikhonova, Katerina; Degryse, Sandrine; Xu, Chengqi; Novero, Domenico; Ponzoni, Maurilio; Tiacci, Enrico; Falini, Brunangelo; Song, Joo; Khodos, Inna; De Stanchina, Elisa; Macari, Gabriele; Cafforio, Luciana; Gardini, Simone; Piva, Roberto; Medico, Enzo; Ng, Samuel Y; Moskowitz, Allison; Epstein, Zachary; Intlekofer, Andrew; Ahmed, Dogan; Chan, Wing C; Martin, Peter; Ruan, Jia; Bertoni, Francesco; Foà, Robin; Brody, Joshua D; Weinstock, David M; Osan, Jaspreet; Santambrogio, Laura; Elemento, Oliver; Betel, Doron; Tam, Wayne; Ruella, Marco; Cerchietti, Leandro; Rabadan, Raul; Horwitz, Steven; Inghirami, Giorgio

Cell Rep Med

Wu G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Yoshida N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Liu J; Harvard Chan Bioinformatics Core, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.; Zhang X; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.; Xiong Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Heavican-Foral TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Nelson GM; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.; Yang L; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016, USA.; Chen R; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016, USA.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Jones MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Roshal M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Xu R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Nirmal AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Jain S; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.; Leahy C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Jones KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Stevenson KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Galasso N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Ganesan N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Chang T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Wu WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Louissaint A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.; Debaize L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Yoon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Dal Cin P; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Chan WC; Department of Pathology, City of Hope Medical Center, Duarte, CA 91010, USA.; Ho Sui SJ; Harvard Chan Bioinformatics Core, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Feldman AL; Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.; Horwitz SM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Adelman K; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Chen CW; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016, USA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.; Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Ahn IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Brander DM; Department of Medicine, Duke University Medical Center, Durham, NC.; Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Zhou Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Walker HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Black R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alencar A; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL.; Shune L; Department of Hematologic Malignancies, University of Kansas Cancer Center, Westwood, KS.; Omaira M; Department of Medical Oncology, West Michigan Cancer Center, Kalamazoo, MI.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Crombie J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Arnason J; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Hochberg EP; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Takvorian RW; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Abramson JS; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Redd RA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Taranto E; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Ahmed G; Medical College of Wisconsin, Milwaukee, WI.; Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; McHugh KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Freedman AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobsen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacene H; Department of Imaging/Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA.; Park H; Department of Imaging/Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA.; Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Joyce RM; Department of Hematologic Malignancy, Beth Israel Deaconess Medical Center, Boston, MA.; Chen YB; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA.; Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Merrill MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Dahi PB; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Redd RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; McDonough MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chen YB; Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.; DeFilipp Z; Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.; Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nieto YL; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.; Sauter CS; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Shah GL; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Zain JM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Merryman, Reid W; Michaud, Laure; Redd, Robert; Mondello, Patrizia; Park, Hyesun; Spilberg, Gabriela; Robertson, Matthew; Taranto, Eleanor; Ahmed, Gulrayz; Chase, Matthew; Jeter, Erin; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer; Davids, Matthew S; Fisher, David C; Jacobsen, Eric; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Ng, Samuel Y; Odejide, Oreofe O; Parry, Erin M; Salles, Gilles; Zelenetz, Andrew D; Armand, Philippe; Schöder, Heiko; Jacene, Heather

Hemasphere
HemaSphere, Vol 7, Iss 2, p e826 (2023)

Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Yoshida N; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Ghandi M; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Dharia NV; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, 450 Brookline Ave, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Dempster J; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Murakami M; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Shigemori K; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Morrow SN; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Van Scoyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Cordero NA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Puligandla M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Haas B; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Lo C; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Meyers R; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Gao G; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Cherniack A; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Louissaint A Jr; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.; Nardi V; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.; Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Long H; Center for Functional Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Qiu X; Center for Functional Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Morgan EA; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02215, USA.; Dorfman DM; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02215, USA.; Fiore D; Department of Pathology, Weill Cornell Medical College, 525 East 68th Street, New York, NY, 10065, USA.; Jang J; Department of Pathology, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.; Epstein AL; Department of Pathology, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.; Dogan A; Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Zhang Y; Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Horwitz SM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Santiago S; Aileron Therapeutics Inc, 281 Albany Street, Cambridge, MA, 02139, USA.; Ren JG; Aileron Therapeutics Inc, 281 Albany Street, Cambridge, MA, 02139, USA.; Guerlavais V; Aileron Therapeutics Inc, 281 Albany Street, Cambridge, MA, 02139, USA.; Annis DA; Aileron Therapeutics Inc, 281 Albany Street, Cambridge, MA, 02139, USA.; Aivado M; Aileron Therapeutics Inc, 281 Albany Street, Cambridge, MA, 02139, USA.; Saleh MN; University of Alabama-Birmingham Comprehensive Cancer Center, 1824 6th Avenue South, Birmingham, AL, 3523, USA.; Mehta A; University of Alabama-Birmingham Comprehensive Cancer Center, 1824 6th Avenue South, Birmingham, AL, 3523, USA.; Tsherniak A; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Root D; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Vazquez F; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Inghirami G; Department of Pathology, Weill Cornell Medical College, 525 East 68th Street, New York, NY, 10065, USA.; Aster JC; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02215, USA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. dweinstock@partners.org.; Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA. dweinstock@partners.org.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. dweinstock@partners.org.; Koch R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. raphael.koch@med.uni-goettingen.de.; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Robert-Koch Str. 40, 37075, Göttingen, Germany. raphael.koch@med.uni-goettingen.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Wu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nelson GM; Department of Biomedical Informatics, Harvard Medical School, Boston, MA.; Koch R; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Gottingen, Germany.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Heavican-Foral TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nirmal AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Yang L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Duffy J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Powers F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Stevenson KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jones MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Wu G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jain S; Massachusetts General Hospital, Boston, MA.; Xu R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Amaka S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Trevisani C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Donaldson NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hagner PR; Bristol Myers Squibb, Summit, NJ.; de Leval L; The Lausanne University Hospital, CHUV, Lausanne, Switzerland.; Gaulard P; Département de Pathologie, Université Paris-Est, Hôpital Henri-Mondor, INSERM U955, Créteil, France.; Iqbal J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE; and.; Thakurta A; Bristol Myers Squibb, Summit, NJ.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Adelman K; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard University, Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Reid_merryman@dfci.harvard.edu.; Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wong JL; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, New York; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, New York.; McHugh K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Reynolds C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nazzaro M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Varden A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jacobsen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, New York.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Joyce RM; Department of Hematologic Malignancy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Chen YB; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, Massachusetts.; Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Yoshida N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.; Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan.; Shigemori K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Donaldson N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Trevisani C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cordero NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.; Bu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Arakawa F; Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan.; Takeuchi M; Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan.; Ohshima K; Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan.; Yoda A; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ng SY; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Davids MS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

Frigault MJ; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA.; Armand P; Department of Medical Oncology and.; Redd RA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.; Jeter E; Department of Medical Oncology and.; Merryman RW; Department of Medical Oncology and.; Coleman KC; Department of Medical Oncology and.; Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.; Dahi P; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Nieto Y; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; LaCasce AS; Department of Medical Oncology and.; Fisher DC; Department of Medical Oncology and.; Ng SY; Department of Medical Oncology and.; Odejide OO; Department of Medical Oncology and.; Freedman AS; Department of Medical Oncology and.; Kim AI; Department of Medical Oncology and.; Crombie JL; Department of Medical Oncology and.; Jacobson CA; Department of Medical Oncology and.; Jacobsen ED; Department of Medical Oncology and.; Wong JL; Department of Medical Oncology and.; Bsat J; Department of Medical Oncology and.; Patel SS; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and.; Ritz J; Department of Medical Oncology and.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and.; Shipp MA; Department of Medical Oncology and.; Chen YB; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA.; Joyce RM; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: samuel_ng@dfci.harvard.edu.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE

Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chen YB; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA.; Redd RA; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.; Joyce RM; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Bsat J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Coleman KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Dahi PB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Freedman AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Wong JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Patel SS; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and.; Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ng SY; Department of Medical Oncology and.; Brown L; Department of Medical Oncology and.; Stevenson K; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; deSouza T; Department of Medical Oncology and.; Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Louissaint A Jr; Department of Pathology, Massachusetts General Hospital, Boston, MA; and.; Weinstock DM; Department of Medical Oncology and.; Broad Institute of MIT and Harvard University, Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Townsend, Elizabeth C; Murakami, Mark A; Christodoulou, Alexandra; Christie, Amanda L; Köster, Johannes; DeSouza, Tiffany A; Morgan, Elizabeth A; Kallgren, Scott P; Liu, Huiyun; Wu, Shuo-Chieh; Plana, Olivia; Montero, Joan; Stevenson, Kristen E; Rao, Prakash; Vadhi, Raga; Andreeff, Michael; Armand, Philippe; Ballen, Karen K; Barzaghi-Rinaudo, Patrizia; Cahill, Sarah; Clark, Rachael A; Cooke, Vesselina G; Davids, Matthew S; DeAngelo, Daniel J; Dorfman, David M; Eaton, Hilary; Ebert, Benjamin L; Etchin, Julia; Firestone, Brant; Fisher, David C; Freedman, Arnold S; Galinsky, Ilene A; Gao, Hui; Garcia, Jacqueline S; Garnache-Ottou, Francine; Graubert, Timothy A; Gutierrez, Alejandro; Halilovic, Ensar; Harris, Marian H; Herbert, Zachary T; Horwitz, Steven M; Inghirami, Giorgio; Intlekofer, Andrew M; Ito, Moriko; Izraeli, Shai; Jacobsen, Eric D; Jacobson, Caron A; Jeay, Sébastien; Jeremias, Irmela; Kelliher, Michelle A; Koch, Raphael; Konopleva, Marina; Kopp, Nadja; Kornblau, Steven M; Kung, Andrew L; Kupper, Thomas S; LeBoeuf, Nicole R; LaCasce, Ann S; Lees, Emma; Li, Loretta S; Look, A Thomas; Murakami, Masato; Muschen, Markus; Neuberg, Donna; Ng, Samuel Y; Odejide, Oreofe O; Orkin, Stuart H; Paquette, Rachel R; Place, Andrew E; Roderick, Justine E; Ryan, Jeremy A; Sallan, Stephen E; Shoji, Brent; Silverman, Lewis B; Soiffer, Robert J; Steensma, David P; Stegmaier, Kimberly; Stone, Richard M; Tamburini, Jerome; Thorner, Aaron R; van Hummelen, Paul; Wadleigh, Martha; Wiesmann, Marion; Weng, Andrew P; Wuerthner, Jens U; Williams, David A; Wollison, Bruce M; Lane, Andrew A; Letai, Anthony; Bertagnolli, Monica M; Ritz, Jerome; Brown, Myles; Long, Henry; Aster, Jon C; Shipp, Margaret A; Griffin, James D; Weinstock, David M

Cancer Cell 29, 574-586 (2016)
Cancer Cell, vol 29, iss 4

Rolland DCM; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.; Basrur V; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Jeon YK; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.; McNeil-Schwalm C; Department of Pediatrics,University of Michigan Medical School, Ann Arbor, MI 48109.; Fermin D; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Conlon KP; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Zhou Y; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; Tsou CC; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Brown NA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Thomas DG; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Bailey NG; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Omenn GS; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109.; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109.; Nesvizhskii AI; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109.; Root DE; The Broad Institute of Massachusetts Institute of Technology and Harvard Medical School, Boston, MA 02142.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; The Broad Institute of Massachusetts Institute of Technology and Harvard Medical School, Boston, MA 02142.; Faryabi RB; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.; Center for Personalized Diagnostics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.; Lim MS; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; kojo.elenitoba-johnson@uphs.upenn.edu megan.lim@uphs.upenn.edu.; Elenitoba-Johnson KSJ; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104; kojo.elenitoba-johnson@uphs.upenn.edu megan.lim@uphs.upenn.edu.; Center for Personalized Diagnostics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Ng SY; aDepartment of Medical Oncology, Dana-Farber Cancer Institute bCenter for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Abramson JS

Publisher: Lippincott Williams And Wilkins Country of Publication: United States NLM ID: 9430802 Publication Model: Print Cited Medium: Internet ISSN: 1531-7048 (Electronic) Linking ISSN: 10656251 NLM ISO Abbreviation: Curr Opin Hematol Subsets: MEDLINE

Wu SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Li LS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Kopp N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Montero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Yoda A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Christodoulou A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; van Bodegom D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; van der Zwet J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Layer JV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Tivey T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Steensma D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harris M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Mandon E; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Ebel N; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Andraos R; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Romanet V; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Dölemeyer A; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Sterker D; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Zender M; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Murakami M; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Hofmann F; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Kuo F; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Eck MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Baffert F; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Vangrevelinghe E; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Radimerski T; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland.; Gaul C; Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland. Electronic address: christoph.gaul@novartis.com.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute, Cambridge, MA 02142, USA. Electronic address: dweinstock@partners.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE